Diabetes Mellitus, Type 2

"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Descriptor ID	D003924
MeSH Number(s)	C18.452.394.750.149 C19.246.300
Concept/Terms	Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 2 Diabetes Mellitus, Noninsulin-Dependent Diabetes Mellitus, Ketosis-Resistant Diabetes Mellitus, Ketosis Resistant Ketosis-Resistant Diabetes Mellitus Diabetes Mellitus, Non Insulin Dependent Diabetes Mellitus, Non-Insulin-Dependent Non-Insulin-Dependent Diabetes Mellitus Diabetes Mellitus, Stable Stable Diabetes Mellitus Diabetes Mellitus, Type II NIDDM Diabetes Mellitus, Noninsulin Dependent Diabetes Mellitus, Maturity-Onset Diabetes Mellitus, Maturity Onset Maturity-Onset Diabetes Mellitus Maturity Onset Diabetes Mellitus MODY Diabetes Mellitus, Slow-Onset Diabetes Mellitus, Slow Onset Slow-Onset Diabetes Mellitus Type 2 Diabetes Mellitus Noninsulin-Dependent Diabetes Mellitus Noninsulin Dependent Diabetes Mellitus Maturity-Onset Diabetes Diabetes, Maturity-Onset Maturity Onset Diabetes Type 2 Diabetes Diabetes, Type 2 Diabetes Mellitus, Adult-Onset Adult-Onset Diabetes Mellitus Diabetes Mellitus, Adult Onset

Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".

Diseases [C]
Nutritional and Metabolic Diseases [C18]
Metabolic Diseases [C18.452]
Glucose Metabolism Disorders [C18.452.394]
Diabetes Mellitus [C18.452.394.750]
Diabetes Mellitus, Type 2 [C18.452.394.750.149]
Endocrine System Diseases [C19]
Diabetes Mellitus [C19.246]
Diabetes Mellitus, Type 2 [C19.246.300]

Below are MeSH descriptors whose meaning is related to "Diabetes Mellitus, Type 2".

Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".

Diabetes Mellitus, Type 2
Diabetes Mellitus, Lipoatrophic

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.

Bar chart showing 536 publications over 30 distinct years, with a maximum of 42 publications in 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	1	0	1
1998	2	0	2
1999	1	0	1
2000	0	1	1
2002	4	1	5
2003	5	0	5
2004	8	6	14
2005	10	2	12
2006	9	2	11
2007	11	4	15
2008	13	2	15
2009	13	12	25
2010	15	2	17
2011	21	7	28
2012	15	4	19
2013	24	6	30
2014	16	4	20
2015	30	6	36
2016	19	8	27
2017	21	5	26
2018	18	5	23
2019	21	5	26
2020	27	3	30
2021	23	2	25
2022	41	1	42
2023	24	1	25
2024	20	5	25
2025	16	1	17
2026	10	2	12

Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.

Zhao C, Hatzikotoulas K, Balasubramanian R, Bertone-Johnson E, Cai N, Huang L, Huerta-Chagoya A, Janiczek M, Ma C, Mandla R, Paluch A, Rayner NW, Southam L, Sturgeon SR, Suzuki K, Taylor HJ, Vankim N, Yin X, Lee CH, Collins F, Spracklen CN. Associations of Combined Genetic and Lifestyle Risks With Incident Type 2 Diabetes in the UK Biobank. Diabetes. 2026 May 01; 75(5):860-866.

View in: PubMed
Huang L, Liu P, Chen Q, Hu K, Li S, Lee A, Wabitsch M, Zhu LJ, Yu Q, Davis R, Czech MP, Wolfe SA, Wang YX. Adissp activates insulin-independent glucose disposal and energy expenditure in white fat to treat diabetes and cardiometabolic disease. Sci Adv. 2026 Apr 24; 12(17):eaed2780.

View in: PubMed
Joshi M, Kim K, Pickard AS, Sharp LK, Gerber BS, Touchette DR. Long-term cost-effectiveness of a mobile health intervention delivered by clinical pharmacists and community health workers for type 2 diabetes management in urban African American and Latinx populations. Am J Health Syst Pharm. 2026 Apr 07; 83(8):423-435.

View in: PubMed
Jaiswal V, Mashkoor Y, Waqas M, Khan MS, Ahmed A, Deb N, Banach M, Dani SS, Zelniker TA, Alexander KM, Fonarow GC, Qamar A. All-cause and cause-specific mortality assessment in patients receiving sodium glucose co-transporter-2 inhibitors. Am J Med. 2026 Aug; 139(8):1032-1042.e19.

View in: PubMed
Wilkie G. Type 2 Diabetes in Pregnancy: Management and Novel Therapies. Clin Obstet Gynecol. 2026 Jun 01; 69(2):203-209.

View in: PubMed
Abdelmoez AM, Jollet M, Yu X, Rizo-Roca D, Marica AA, Ortiz de Zevallos J, Dollet L, Borg ML, Bj?rnholm M, Checa A, Olsson T, Otten J, Zierath JR, Krook A, Schwartz TW, Chibalin AV, Pillon NJ. Thromboxane signalling links immune activation to enhanced glucose uptake in skeletal muscle. Diabetologia. 2026 Jun; 69(6):1643-1658.

View in: PubMed
Schuppelius B, Lalama E, Zhang J, Ruether K, Csanalosi M, Kabisch S, Christ A, Latz E, Kraenkel N, Pivovarova-Ramich O, Mai K, Pfeiffer AFH. Remission of type 2 diabetes depends on time since diagnosis and low-calorie diet composition: Results of a randomized controlled trial in individuals with overweight and obesity. Diabetes Res Clin Pract. 2026 Mar; 233:113159.

View in: PubMed
Joshi M, Kim K, Pickard AS, Sharp LK, Gerber BS, Touchette DR. Mobile health intervention for type 2 diabetes management delivered by community health workers and clinical pharmacists: Intervention costs and healthcare resource utilization. Am J Health Syst Pharm. 2026 Jan 27; 83(3):e116-e125.

View in: PubMed
Deng C, Zheng J, Xu F, Hong F, Zhan M, Chen Q, Peng Y, Cao Y, Xiao J, Liao Y, Xiao H, Song M. Processing-induced structural remodeling enhances the hypoglycemic activity of Polygonatum cyrtonema Hua polysaccharides via gut microbiota-SCFA-GPR41/43 pathway. Food Res Int. 2026 Apr 01; 229:118492.

View in: PubMed
Verma A, Upadhyay A. Diabetic kidney disease, biomarkers, and finerenone. Diabetes Obes Metab. 2026 Apr; 28(4):2582-2593.

View in: PubMed

People

Explore

Similar Concepts

Top Journals